Reata Pharmaceuticals, Inc. Announces Third Quarter 2016 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. NVDA
2. PCG
3. AVGO
4. CNS
5. AMZN
6. STLA
7. ALNY
8. HDB
9. ATTO
10. BRVE

Go back to Reata Pharmaceuticals, Inc. Announces Third Quarter 2016 Financial and Operating Results

Reata Pharma (RETA) Tops Q3 EPS by 10c

November 14, 2016 8:35 AM EST

Reata Pharma (NASDAQ: RETA) reported Q3 EPS of ($0.04), $0.10 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.55 million versus the consensus estimate of $12.46 million.

For earnings history and earnings-related data on Reata Pharma (RETA) click here.

... More